ArticleFrontiers in neuroscience2025
Advanced neural activity mapping in brain organoids via field potential imaging with ultra-high-density CMOS microelectrode arrays.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human iPSC-Derived Brain Organoids: A Disease-Oriented Evaluation of Modeling Fidelity.The European journal of neuroscience · 2026Review
- 360° size-adjustable microelectrode array system for electrophysiological monitoring of cerebral organoids.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human iPSC-derived brain organoids and assembloids have emerged as promising in vitro models for recapitulating human brain development, neurological disorders, and drug responses. However, detailed analysis of their electrophysiological properties requires advanced measurement techniques. Methods: Here, we present an analytical approach using ultra-high-density (UHD) CMOS microelectrode arrays (MEAs) with 236,880 electrodes across a 32.45 mm2 sensing area, enabling large-scale field potential imaging (FPI) of brain organoids. Results: Neuronal activity was recorded from over 46,000 electrodes, allowing single-cell spike detection and network connectivity analysis. In midbrain organoids, L-DOPA administration elicited both excitatory and inhibitory responses, with a dose-dependent shift toward network enhancement. Leveraging the spatiotemporal resolution of the UHD-CMOSMEA, we introduced two novel endpoints: propagation velocity and propagation area. In cortical organoids, picrotoxin increased propagation velocity, while MK-801 reduced propagation area. FPI also enabled frequency-domain analyses, revealing region-specific activity, including distinct gamma-band patterns. In midbrain-striatal assembloids, 4-aminopyridine enhanced interorganoid connectivity. Conclusion: This single-cell-resolved, large-scale recording approach using UHD-CMOS MEAs enables detailed analysis of network connectivity, propagation dynamics, and frequency features. It provides a powerful platform for studying brain organoids and assembloids, with strong potential for drug discovery and disease modeling in human neuroscience.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.